Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07557030 · ClinicalTrials.gov registry record · NA
Optimization for Toric Contact Lenses
A NA study, sponsored by CooperVision International Limited (CVIL).
- Not yet
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07557030 is a NA study that has not yet begun recruiting, run by CooperVision International Limited (CVIL). The registered enrollment target is 45 participants.
The verdict
NCT07557030, a NA study, has not yet begun recruiting, sponsored by CooperVision International Limited (CVIL).
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate the agreement between subjective and objective toric lens prescriptions.
Interventions
- DEVICE Lens 1 ( stenfilcon A )
- DEVICE Lens 2 ( comfilcon A )
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-05 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07557030
The ClinicalTrials.gov registry entry for NCT07557030 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision International Limited (CVIL), which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lens 1 ( stenfilcon A ) is the first listed.
NCT07557030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07557030 about?
NCT07557030 is a clinical study titled "Optimization for Toric Contact Lenses". The aim of this study is to evaluate the agreement between subjective and objective toric lens prescriptions.
What is the current status of trial NCT07557030?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-05. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07557030?
The interventions under investigation include: Lens 1 ( stenfilcon A ) (DEVICE), Lens 2 ( comfilcon A ) (DEVICE).
Who is sponsoring clinical trial NCT07557030?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.